IQVIA(IQV)
Search documents
IQVIA(IQV) - 2024 Q1 - Earnings Call Presentation
2024-05-02 16:37
100% 50% 75% 25% 100% 50% 75% 25% This presentation should be viewed in conjunction with IQVIA's Q1 2024 earnings call In all cases where historical results are presented or past performance is described, we note that past performance is not a reliable indicator of future results and performance. Legal IQVIA Template (V2.1.0) 1 st Quarter Balance Sheet and Cash Flow Items and Metrics Dollars are at actual foreign exchange rates. (1) Calculated using last twelve months Adjusted EBITDA. (2) See reconciliation ...
IQVIA(IQV) - 2024 Q1 - Earnings Call Transcript
2024-05-02 14:58
Kerri Joseph - Senior Vice President, Investor Relations and Treasury Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice President and Chief Financial Officer Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA First Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakersÂ' remarks, there will be a question-and-answer session. [Operator Instructions] A ...
IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates
Zacks Investment Research· 2024-05-02 13:11
IQVIA Holdings (IQV) came out with quarterly earnings of $2.54 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.45 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.83%. A quarter ago, it was expected that this clinical testing company would post earnings of $2.82 per share when it actually produced earnings of $2.84, delivering a surprise of 0.71%.Over the last four quarters, ...
IQVIA(IQV) - 2024 Q1 - Quarterly Results
2024-05-02 12:41
Exhibit 99.1 IQVIA Reports First-Quarter 2024 Results • Revenue of $3,737 million • GAAP Net Income of $288 million, Adjusted EBITDA of $862 million • GAAP Diluted Earnings per Share of $1.56, Adjusted Diluted Earnings per Share of $2.54 • R&D Solutions quarterly bookings of $2.6 billion, representing a book-to-bill ratio of 1.23x • R&D Solutions contracted backlog of $30.1 billion, up 7.9 percent year-over-year RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – May 2, 2024 – IQVIA Holdings Inc. (“IQVIA”) (NY ...
IQVIA (IQV) to Report Q1 Earnings: What's in the Offing?
Zacks Investment Research· 2024-04-29 15:30
IQVIA Holdings, Inc. (IQV) is scheduled to release its first-quarter 2024 results on May 2, before market open.IQV has an impressive earnings surprise history, having surpassed the Zacks Consensus Estimate in each of the four trailing quarters, the average surprise being 1.5%.Q1 ExpectationsThe Zacks Consensus Estimate for the top line is currently pegged at $3.7 billion, up 1.1% from the year-ago quarter. The growth in revenues is likely to have been due to an uptick in demand of clients, strategic acquisi ...
Countdown to IQVIA (IQV) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Zacks Investment Research· 2024-04-29 14:22
Wall Street analysts expect IQVIA Holdings (IQV) to post quarterly earnings of $2.47 per share in its upcoming report, which indicates a year-over-year increase of 0.8%. Revenues are expected to be $3.69 billion, up 1.1% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Ahead of a company's earnings disclosure, it is cr ...
Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now
Zacks Investment Research· 2024-04-17 17:01
IQVIA Holdings (IQV) stock has gained 7.5%, outperforming 2.5% and 6.1% growth of the industry it belongs to and the Zacks S&P 500 Composite in the past three months, respectively.IQV has an expected long-term (three to five years) EPS growth rate of 10.2%. The company’s earnings for 2024 and 2025 are anticipated to grow 8.6% and 13% year over year, respectively. Revenues are expected to increase 3.5% in 2024 and 7.9% in 2025.Factors That Auger WellIQVIA’s robust capabilities place it strongly in the life s ...
IQVIA(IQV) - 2023 Q4 - Annual Report
2024-02-15 12:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 27-1341991 (State or other jurisdiction ...
IQVIA(IQV) - 2023 Q4 - Earnings Call Transcript
2024-02-14 20:31
IQVIA Holdings, Inc. (NYSE:IQV) Q3 2023 Earnings Conference Call February 14, 2024 9:00 AM ET Nicholas Childs - SVP, IR and Treasury Ari Bousbib - Chairman, President and CEO Ronald Bruehlman - EVP and CFO Anne Samuel - JPMorgan Shlomo Rosenbaum - Stifel Tejas Savant - Morgan Stanley Luke Sergott - Barclays Elizabeth Anderson - Evercore ISI David Windley - Jefferies I would now like to turn the call over to Nick Childs, Senior Vice President, Investor Relations and Treasury. Mr. Childs, please begin your co ...
IQVIA(IQV) - 2023 Q3 - Quarterly Report
2023-11-01 20:29
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 __ ...